Tamarack Advisers’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.61M | Sell |
|
|||||
|
2023
Q1 | $2.64M | Sell |
|
|||||
|
2022
Q4 | $3.45M | Buy |
|
|||||
|
2022
Q3 | $2.36M | Hold |
|
|||||
|
2022
Q2 | $2.26M | Sell |
|
|||||
|
2022
Q1 | $9.72M | Sell |
|
|||||
|
2021
Q4 | $11.9M | Sell |
|
|||||
|
2021
Q3 | $25.4M | Buy |
|
|||||
|
2021
Q2 | $27.8M | Sell |
|
|||||
|
2021
Q1 | $28.6M | Buy |
|
|||||
|
2020
Q4 | $26M | Sell |
|
|||||
|
2020
Q3 | $18M | Buy |
|
|||||
|
2020
Q2 | $12.5M | Buy |
|
|||||
|
2020
Q1 | $8.66M | Sell |
|
|||||
|
2019
Q4 | $11.8M | Buy |
|
|||||
|
2019
Q3 | $10.2M | Hold |
|
|||||
|
2019
Q2 | $14M | Buy |
|
|||||
|
2019
Q1 | $13.6M | Sell |
|
|||||
|
2018
Q4 | $12.7M | Buy |
|
|||||
|
2018
Q3 | $14.6M | Buy |
|
|||||
|
2018
Q2 | $7.43M | Buy |
|